usugm 2014 - gregory landrum (novartis): what else can you do with the markush cartridge?
TRANSCRIPT
What else can you do with the Markush cartridge? Tracking chemical series for project teams
Gregory Landrum Ph.D., Anna Pelliccioli Ph.D. NIBR Informatics
Novartis Institutes for BioMedical Research
Basel
ChemAxon UGM 2014 Cambridge, MA
The Problem
§ Medicinal chemists frequently use the idea of the “Series” as an organizing principle.
§ A compound belongs to a Series if its structure contains a particular substructure or scaffold
§ Scaffold definitions are ‘in the Chemist’s head’ or in some local files § Learnings/decisions from med chem projects are typically associated
with the individual series. • “We were unable to achieve selectivity with series A” • “Series B has metabolic liabilities” • “We decided to start lead-optimization activities with series C”
§ Series-level knowledge stays with scientists or, at best, in slide decks
The Compound Series and Favorites Project (CSF)
§ Provide scientists with a shared space to store scaffold definitions and most significant compounds (Favorites).
§ Structures should be searchable within the new application § Scientists should be able to annotate structures and scaffolds to
capture their learnings § Everything should be accessible from other applications (like Spotfire)
via web services
An aside
§ All structures and data in this presentation are taken from public data sources: • Neil R. Curtis, Janusz J. Kulagowski, Paul D. Leeson, Mark P. Ridgill, Frances Emms, Stephen B.
Freedman, Shil Patel, Smita Patel, 1999, 'Synthesis and sar of 2- and 3-substituted 7-azaindoles as potential dopamine D4 ligands', Bioorganic & Medicinal Chemistry Letters, vol. 9, no. 4, pp. 585-588
• Thomas R. Belliotti, Wouter A. Brink, Suzanne R. Kesten, John R. Rubin, David J. Wustrow, Kim T. Zoski, Steven Z. Whetzel, Ann E. Corbin, Thomas A. Pugsley, Thomas G. Heffner, Lawrence D. Wise, 1998, 'Isoindolinone enantiomers having affinity for the dopamine D4 receptor', Bioorganic & Medicinal Chemistry Letters, vol. 8, no. 12, pp. 1499-1502
• Christian Haubmann, Harald Hübner, Peter Gmeiner, 1999, 'Piperidinylpyrroles: Design, synthesis and binding properties of novel and selective dopamine D4 receptor ligands', Bioorganic & Medicinal Chemistry Letters, vol. 9, no. 21, pp. 3143-3146
• Hubert H. M. Van Tol, James R. Bunzow, Hong-Chang Guan, Roger K. Sunahara, Philip Seeman, Hyman B. Niznik, Olivier Civelli, 1991, 'Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine', Nature, vol. 350, no. 6319, pp. 610-614
• Jalaj Arora, Michel Bordeleau, Laurence Dube, Keith Jarvie, Lucy Mazzocco, Jack Peragine, Ashok Tehim, Ian Egle, 2005, 'N-[(3S)-1-Benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: Human dopamine D4 ligands with high affinity for the 5-HT2A receptor', Bioorganic & Medicinal Chemistry Letters, vol. 15, no. 23, pp. 5253-5256
§ Chemical structures exported from ChEMBL 19.
CSF – the system
§ Web-based front end: • Bootstrap + JQuery • ChemDraw • Avalon toolkit for structure rendering • Calls out to multiple NIBR services
§ CSF Service Layer: • Java-based REST services • RDKit for structure validation
§ Database:
• Oracle + JChem + Markush extensions
Markush features
Several Markush features can be used to define scaffolds Not all features are supported: depends on what the cartridge can store as a target and what our internal renderer can display
Integration with other tools: Spotfire
Selecting scaffolds/compounds Lists populated from CSF’s service layer
Acknowledgements § Project team
• Anna Pelliccioli • Manuel Schwarze • Recca Chatterjee • Mikhail Rybalkin • Roman Bolshev
§ Acceptance Team • Natalie Dales • Stefanie Flohr • Greg Hollingworth • Patrick Lee • Wolfgang Miltz • Ansgar Schuffenhauer
§ Advisory Team • Mark Burfoot • John Davies • Jeremy Jenkins • Greg Landrum • Greg Paris • Tim Smith
§ Others • Nico Pulver • Guido Koch • Hans Widmer
§ ChemAxon • Andras Volford